Mid-Yorkshire Hospitals

Slides:



Advertisements
Similar presentations
Standardising Chemotherapy Nursing Practice across a Cancer Network Claire Kelly Network Lead Nurse Cancer Care Alliance of Teesside, South Durham & North.
Advertisements

March 2002 Outcomes in thyroid cancer: what factors are important? Information Projects Team Outcomes in thyroid cancer: what factors are important? NYCRIS.
Guidance on Cancer Services Improving Outcomes for People with Skin Tumours including Melanoma NICE Stateholder Consultation version July 2005.
Nurse terminology model Dr. Rodney Hughes North Wales Nursing Terminology Group.
Your GP record and working together Dr Duncan Gooch and Tom Atack.
Clinical Audit as Evidence for Revalidation Dr David Scott, GMC Associate, Consultant Paediatrician and Clinical Lead for Children’s Services, East Sussex.
Conducting Research in the UK National Health Service Dr Stephen Brett Reader In Critical Care.
Commissioning for a New Era. The challenges we face…
Integrated Health System Planning An exclusive Executive Circle Briefing.
Evidence, guidelines and practice: the way forward in a digital age SYDNEY 11 April, 2013 Bill Runciman Professor – Patient Safety & Healthcare Human Factors.
Follow-up on Abnormal Cancer Screenings: Creating a system-wide, EMR-based solution to improve patient safety and reduce medical errors Cambridge Health.
Care in Crisis - the challenge Carol Herity – Head of Partnerships.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
The Medical Team Stanley Silverman MD FRCS Consultant Vascular Surgeon Medical Director West Midlands Strategic Health Authority West Midlands Strategic.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
Quality Measures Workgroup David Lansky, PhD 1. Quality Measures Workgroup 2012 Stage 2 Quality Measure Development Stage 2 NPRM Review Alignment with.
Improving Outcomes for Children & Young People with Cancer Louise Hooker National Cancer Action Team Cancer Action Team Cancer.
Gynaecology MDT Coordinator
Carlos Rocha Registry Manager National Cancer Registration Service (South West) West Dean Registration Improvement of Non-Melanoma skin cancer.
QUESTIONS TO DEBATE Chapter 5, Instructor’s Manual.
Better Care Better Health Better Life Leadership Framework The Leadership Framework is based on the concept that leadership is not restricted to people.
The future use of Electronic Health Records for reshaped health statistics: opportunities and challenges in the Australian context Denise Carlton Director.
Bedfordshire CCG - Our Story Health and Wellbeing Stakeholder Event 1 February 2013 John Rooke, Chief Operating Officer 1.
Implementation of Breast Stratified Follow- up in North East London: Barts Breast Open Access Follow up Mr. Anthony Peel Clinical Lead and Consultant Breast.
[NAME CCG] [DATE] [FACILITATOR] Early Diagnosis of Cancer Quality Improvement using Cancer Significant Event Analysis [CCG MAP]
PATHOLOGY HEALTH SERVICES SYDNEY. DOUGLASS HANLY MOIR PATHOLOGY Douglass Hanly Moir PathologyDouglass Hanly Moir Pathologyprovides a state-of-the-art.
Case for change Burden of disease – each week around 250 diagnoses and 115 deaths in West Yorkshire. Cancer ‘roadmap’ set out in FYFV and Cancer Taskforce.
County Durham, Darlington, Teesside, Hambleton, Richmondshire and Whitby Sustainability and Transformation Plan “Meeting patient needs now and future.
Title of the Change Project
South Yorkshire and Bassetlaw Sustainability and Transformation Plan
Do you want to be involved?
Proposed Cataract Pathway
Impact of Technology on Quality & Safety Initiatives
CRUK working group MDT effectiveness proposal
Improving outcomes in acute spinal cord injury (tetraplegia/paraplegia) PAMC ICU Outcomes Data 2017.
Multi-Disciplinary Team Meeting Reforms
PROMOTING PATIENT SAFETY BY PREVENTING MEDICAL ERRORS
Does One Size Fit All in Obesity Management?
Stratified Breast Pathways
Preconditions of chronic disease March 2018
Home First.
Management of Vulval Melanoma
دانشگاه علوم پزشکی بوشهر دانشکده بهداشت
دانشگاه علوم پزشکی بوشهر دانشکده بهداشت
Making MDTs better Steve Falk
Getting To Know You Yorkshire Cancer Patient Forum Event Tuesday 3rd October 2017 Wrapping Services Around the Patient – West Yorkshire and Harrogate Cancer.
‘Improving Outcomes for people with skin tumours, including Melanoma’
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
Multi-Disciplinary Team Meeting Reforms
Worcestershire Colorectal Cancer 2ww Pathway
Multi-Disciplinary Team Meeting Reforms
Worcestershire Joint Services Review
Multi-Disciplinary Team Meeting Reforms
Jaspal Phull Somerset, Wiltshire, Avon and Gloucestershire (SWAG) Cancer Service.
Review of Joint CCG Committee Remit
Working together to support patients with long-term conditions
Cancer Patient Experience Survey, by Sex, England Female Male Persons
May 2019 <0.8% 0.7% <3.2% 3.6% Cancelled Operations
MULTIDISCIPLINARY (MDT) APPROACH TO CLINICAL CARE MODEL FOR EFFECTIVE AND BEST EVIDENCE PATIENT CARE DR EZEKIEL ALAWALE MBBS, FWACS, FRCS(I), JCPTGP, GP.
NCL Teledermatology Service Lead by:
STAND- Support Through Art and Networking in Diabetes A psychotherapeutic group for adolescent patients and their parents Helen O’Byrne 14th June 2019.
ACCORD All Cause Clinical & Organisational Response to Deterioration
Squamous cell carcinoma pathway update
Multidisciplinary Team Meeting Breast Care
Airedale NHS Foundation Trust
Calderdale and Huddersfield NHS Foundation Trust
York Teaching Hospitals NHS Trust
NHS Long Term Plan: Rapid Diagnostic Centres (RDC) The SWAG Approach
Leeds Teaching Hospitals Trust
MDTM Reforms from a Pathology Perspective
Presentation transcript:

Mid-Yorkshire Hospitals Skin Cancer MDT Dr David Fairhurst “Could some patients be streamlined or reviewed outside of the (MDT) meeting, providing that this was undertaken to a strict protocol?” The Cancer Alliance is part of West Yorkshire and Harrogate Health and Care Partnership - www.canceralliance.wyhpartnership.co.uk Twitter: @WYHpartnership or @profseanduffy

Approach used The management of certain low risk skin cancers is entirely standardised and based solely on the pathologists report

Issues Protocol agreed: Stage 1A and in-situ Melanomas Exclusion criteria set All cases have full pathology review prior to MDT meeting If no changes to report (staging) management proceeds as per existing clinical protocols Standardised minutes

Challenges Nil significant 4 cases had full MDT discussion (within exclusion criteria)

Outcomes Average of 4 cases per meeting (0-8) 44 cases reviewed Zero changes to original report No safety or outcome concerns Efficient use of time within MDT meetings Focus on high risk patients that benefit from clinical discussion

Any questions?